Poor + Pharmaceutical assistance -- United States
Label
Poor + Pharmaceutical assistance -- United States
Name
Poor + Pharmaceutical assistance
Actions
Incoming Resources
- Subject of16
- The fiscal year 2022 HHS budget, virtual hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventeenth Congress, first session, May 12, 2021
- Assessing the design of the low-income subsidy program in Medicare Part D, Andrew Stocking [and three others]
- Examining the 340B drug pricing program, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 24, 2015
- Medicare programs for low-income beneficiaries, hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Tenth Congress, first session, May 3, 2007
- Medicare Part D low-income subsidy, progress made in approving applications, but ability to identify remaining individuals is limited : testimony before the Senate Committee on Finance, statement of Barbara Bovbjerg
- Perspectives on the 340B Drug Pricing Program, hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B drug discount program, March 15, 2018
- Medicare Part D low-income subsidy, SSA continues to approve applicants, but millions of individuals have not yet applied : testimony before the Special Committee on Aging, U.S. Senate, statement of Barbara D. Bovbjerg
- Effective administration of the 340B Drug Pricing Program, hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining effective administration of the 340B Drug Pricing Program, June 19, 2018
- Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies, testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives, / statement of Debra A. Draper
- Examining how covered entities utilize the 340B drug pricing program, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017
- Examining HRSA's oversight of the 340B Drug Pricing Program, hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017
- Opportunities to improve the 340B drug pricing program, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 11, 2018
- 340B Drug Discount Program, information about hospitals that received an eligibility exception as a result of COVID-19
- Seniors at risk, improving Medicare for our most vulnerable : hearing before the Special Committee on Aging, United States Senate, One Hundred Tenth Congress, second session, Washington, DC, May 22, 2008
- Medicare Part D low-income subsidy, additional efforts would help Social Security improve outreach and measure program effects : report to the Committee on Finance, U.S. Senate
- Prescription drug discount coupons and patient assistance programs (PAPs), Suzanne M. Kirchhoff